ArticleCancer chemotherapy and pharmacology2021
Repurposing proscillaridin A in combination with decitabine against embryonal rhabdomyosarcoma RD cells.
Marielle Huot et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it